IBDEI14N ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18098,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,18098,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,18099,0)
 ;;=E11.630^^88^909^33
 ;;^UTILITY(U,$J,358.3,18099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18099,1,3,0)
 ;;=3^DM Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,18099,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,18099,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,18100,0)
 ;;=E11.638^^88^909^29
 ;;^UTILITY(U,$J,358.3,18100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18100,1,3,0)
 ;;=3^DM Type 2 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,18100,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,18100,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,18101,0)
 ;;=E11.641^^88^909^20
 ;;^UTILITY(U,$J,358.3,18101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18101,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,18101,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,18101,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,18102,0)
 ;;=E11.649^^88^909^21
 ;;^UTILITY(U,$J,358.3,18102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18102,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,18102,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,18102,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,18103,0)
 ;;=E11.65^^88^909^17
 ;;^UTILITY(U,$J,358.3,18103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18103,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,18103,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,18103,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,18104,0)
 ;;=E11.69^^88^909^32
 ;;^UTILITY(U,$J,358.3,18104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18104,1,3,0)
 ;;=3^DM Type 2 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,18104,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,18104,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,18105,0)
 ;;=E11.8^^88^909^34
 ;;^UTILITY(U,$J,358.3,18105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18105,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,18105,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,18105,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,18106,0)
 ;;=E11.9^^88^909^35
 ;;^UTILITY(U,$J,358.3,18106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18106,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,18106,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,18106,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,18107,0)
 ;;=E11.29^^88^909^27
 ;;^UTILITY(U,$J,358.3,18107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18107,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Kidney Compl
 ;;^UTILITY(U,$J,358.3,18107,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,18107,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,18108,0)
 ;;=E11.311^^88^909^14
 ;;^UTILITY(U,$J,358.3,18108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18108,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,18108,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,18108,2)
 ;;=E11.319^5002632
 ;;^UTILITY(U,$J,358.3,18109,0)
 ;;=E11.319^^88^909^15
 ;;^UTILITY(U,$J,358.3,18109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18109,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,18109,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,18109,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,18110,0)
 ;;=E11.3211^^88^909^22
 ;;^UTILITY(U,$J,358.3,18110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18110,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
 ;;^UTILITY(U,$J,358.3,18110,1,4,0)
 ;;=4^E11.3211
